APA WF# 24-32 Removing Certain Drugs from 340b Program
These proposed policy changes are being promulgated as Permanent Rules.
These rule revisions seek to remove certain drugs and therapies from the 340b Drug Pricing Program. The 340b program is a federal initiative that allows health care organizations to purchase certain drugs at a discount direct from pharmaceutical manufacturers. One restriction on this program is that no rebates can be collected from any drug or therapy purchased under the program, including supplemental rebates. These revisions would prohibit purchasing drugs which are in a supplemental rebate agreement from being purchased under the 340b program.
Please view the circulation documents here: APA WF# 24-32 and submit feedback via the comment box.
Circulation Date: 12/2/2024
Comment Due Date: 1/6/2025
Public Hearing: 1/6/2025
Board Meeting: 1/15/2025
Submit a Comment
After you submit your comment, you should be re-directed to a confirmation page. If you are not, please submit your comment through e-mail to federal.authorities@okhca.org.
Please note that all comments must be reviewed and approved prior to posting. Approved comments will be posted Monday through Friday between the hours of 7:30 a.m. – 4 p.m. Any comments received after 4 p.m. will be posted on the following business day.
Comments
No comments.
